5'-O-{N-[11-(Phenylamino)undecanoyl]sulfamoyl}adenosine

ID: ALA4791695

Chembl Id: CHEMBL4791695

PubChem CID: 162670828

Max Phase: Preclinical

Molecular Formula: C27H39N7O7S

Molecular Weight: 605.72

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1ncn2[C@@H]1O[C@H](COS(=O)(=O)NC(=O)CCCCCCCCCCNc2ccccc2)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C27H39N7O7S/c28-25-22-26(31-17-30-25)34(18-32-22)27-24(37)23(36)20(41-27)16-40-42(38,39)33-21(35)14-10-5-3-1-2-4-6-11-15-29-19-12-8-7-9-13-19/h7-9,12-13,17-18,20,23-24,27,29,36-37H,1-6,10-11,14-16H2,(H,33,35)(H2,28,30,31)/t20-,23-,24-,27-/m1/s1

Standard InChI Key:  WJBZSIDEJTZCLE-ZCIWVVNKSA-N

Alternative Forms

  1. Parent:

    ALA4791695

    ---

Associated Targets(non-human)

Mycobacterium tuberculosis (203094 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
fadD19 PROBABLE FATTY-ACID-CoA LIGASE FADD19 (FATTY-ACID-CoA SYNTHETASE) (FATTY-ACID-CoA SYNTHASE) (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
fadD28 Acyl-CoA synthase (418 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 605.72Molecular Weight (Monoisotopic): 605.2632AlogP: 2.03#Rotatable Bonds: 17
Polar Surface Area: 203.81Molecular Species: ACIDHBA: 13HBD: 5
#RO5 Violations: 2HBA (Lipinski): 14HBD (Lipinski): 6#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.04CX Basic pKa: 5.17CX LogP: 1.39CX LogD: 1.22
Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.14Np Likeness Score: 0.21

References

1. Baran M,Grimes KD,Sibbald PA,Fu P,Boshoff HIM,Wilson DJ,Aldrich CC.  (2020)  Development of small-molecule inhibitors of fatty acyl-AMP and fatty acyl-CoA ligases in Mycobacterium tuberculosis.,  201  [PMID:32574901] [10.1016/j.ejmech.2020.112408]

Source